Redwire stock
Redwire Corporation (NYSE: RDW) announced on September 4, 2026, a strategic collaboration with Eli Lilly and Company to utilize Redwire’s "ADSEP" pharmaceutical in--space manufacturing platform for advanced protein crystallization studies. This mission, scheduled for launch in late 2026, aims to leverage the microgravity environment of the International Space Station (ISS) to develop more effective drug formulations. This partnership highlights the growing commercial interest in space--based biopharma research and Redwire's role as a key infrastructure provider for orbital life sciences. Management is expected to provide further details on the commercial roadmap for space--based drug development during the Investor Day on September 22, 2026.